Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Fenwick

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Infectious Diseases and Therapy|January 14, 2024
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal AntibodiesNorman Moullan, Josephat Asiago, Kathryn Stecco, et al.
Nature Communications|August 10, 2021
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patientsMatthieu Perreau, Madeleine Suffiotti, Pedro Marques-Vidal, et al.
Communications Medicine|November 30, 2024
Features of chronic urticaria after COVID-19 mRNA vaccine over timeJohan Schwab, Mathilde Foglierini, Eva Pescosolido, et al.
Journal for Immunotherapy of Cancer|October 23, 2021
<sup>68</sup>Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditisSarah Boughdad, Sofiya Latifyan, Craig Fenwick, et al.
The Journal of Infection|June 15, 2023
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patientsBenedict Fallet, Mathilde Foglierini, Raphael Porret, et al.
Nature Communications|August 18, 2022
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohortDominik Menges, Kyra D Zens, Tala Ballouz, et al.
Journal of Virology|November 4, 2020
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence StudiesCraig Fenwick, Antony Croxatto, Alix T Coste, et al.
Frontiers in Immunology|September 12, 2022
The deficiency in Th2-like Tfh cells affects the maturation and quality of HIV-specific B cell response in viremic infectionAlessandra Noto, Madeleine Suffiotti, Victor Joo, et al.
Plos Pathogens|November 30, 2020
TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized miceVéronique Godot, Colas Tcherakian, Laurine Gil, et al.
Journal of Clinical Immunology|March 21, 2023
Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19Hakim Hocini, Aurélie Wiedemann, Fabiola Blengio, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Infectious Diseases and Therapy|January 14, 2024
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal AntibodiesNorman Moullan, Josephat Asiago, Kathryn Stecco, et al.
Nature Communications|August 10, 2021
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patientsMatthieu Perreau, Madeleine Suffiotti, Pedro Marques-Vidal, et al.
Communications Medicine|November 30, 2024
Features of chronic urticaria after COVID-19 mRNA vaccine over timeJohan Schwab, Mathilde Foglierini, Eva Pescosolido, et al.
Journal for Immunotherapy of Cancer|October 23, 2021
<sup>68</sup>Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditisSarah Boughdad, Sofiya Latifyan, Craig Fenwick, et al.
The Journal of Infection|June 15, 2023
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patientsBenedict Fallet, Mathilde Foglierini, Raphael Porret, et al.
Nature Communications|August 18, 2022
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohortDominik Menges, Kyra D Zens, Tala Ballouz, et al.
Journal of Virology|November 4, 2020
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence StudiesCraig Fenwick, Antony Croxatto, Alix T Coste, et al.
Frontiers in Immunology|September 12, 2022
The deficiency in Th2-like Tfh cells affects the maturation and quality of HIV-specific B cell response in viremic infectionAlessandra Noto, Madeleine Suffiotti, Victor Joo, et al.
Plos Pathogens|November 30, 2020
TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized miceVéronique Godot, Colas Tcherakian, Laurine Gil, et al.
Journal of Clinical Immunology|March 21, 2023
Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19Hakim Hocini, Aurélie Wiedemann, Fabiola Blengio, et al.
Pageof 7